Takeda Pharmaceutical Co (LTS:0A87) Investments And Advances : $2,428 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Takeda Pharmaceutical Co Investments And Advances?

Takeda Pharmaceutical Co's Investments And Advances for the quarter that ended in Mar. 2025 was $2,428 Mil.

Takeda Pharmaceutical Co's quarterly Investments And Advances increased from Sep. 2024 ($1,940 Mil) to Dec. 2024 ($2,667 Mil) but then declined from Dec. 2024 ($2,667 Mil) to Mar. 2025 ($2,428 Mil).

Takeda Pharmaceutical Co's annual Investments And Advances increased from Mar. 2023 ($2,834 Mil) to Mar. 2024 ($2,874 Mil) but then declined from Mar. 2024 ($2,874 Mil) to Mar. 2025 ($2,428 Mil).

Takeda Pharmaceutical Co Investments And Advances Historical Data

The historical data trend for Takeda Pharmaceutical Co's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Investments And Advances Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Investments And Advances

Get a 7-Day Free Trial

3,204.72

2,784.11

2,834.39

2,874.20

2,428.10

Takeda Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Investments And Advances	Get a 7-Day Free Trial															2,874.20	2,832.77	1,939.88	2,666.89	2,428.10

Takeda Pharmaceutical Co Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (LTS:0A87) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan TKD:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines